High Immunogenicity to Influenza Vaccination in Crohn’s Disease Patients Treated with Ustekinumab

Influenza vaccination can be less effective in patients treated with immunosuppressive therapy. However, little is known about the effects of ustekinumab; an anti-IL-12/23 agent used to treat Crohn’s disease (CD), on vaccination response. In this prospective study, we assessed immune responses to se...

Descripción completa

Detalles Bibliográficos
Autores principales: Doornekamp, Laura, Goetgebuer, Rogier L., Schmitz, Katharina S., Goeijenbier, Marco, van der Woude, C. Janneke, Fouchier, Ron, van Gorp, Eric C.M., de Vries, Annemarie C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565576/
https://www.ncbi.nlm.nih.gov/pubmed/32824111
http://dx.doi.org/10.3390/vaccines8030455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7565576/
https://www.ncbi.nlm.nih.gov/pubmed/32824111
http://dx.doi.org/10.3390/vaccines8030455

Ejemplares similares